Navigation Links
Unigene Laboratories Granted US Patent for Peptide-Based Technology for Treatment of Obesity
Date:1/11/2012

clinical studies of UGP281 before the end of 2012; the lead molecule for the Type 2 diabetes indication will be selected by the Company with Nordic, early-stage preclinical studies will be conducted and the preclinical results of a lead molecule will be reported in the second half of 2012; at least one feasibility study will convert into a high-value milestone and royalty payment licensing agreement over the next 6-9 months; Cara will report the results from its Phase 1 study in the first quarter of 2012; the Company is well positioned to capitalize on the numerous opportunities that its oral peptide delivery platform and pipeline are expected to realize in 2012; the Company will secure a development partner and licensee for its oral PTH program and, if so, whether it will become a game-changing treatment option for the estimated 75 million people in Europe, the US and Japan who are impacted by osteoporosis; the Company and its stockholders will reap rewards and achieve substantial growth in 2012; and the Company's current cash flow will be sufficient to fund its business operations into the second half of 2012.  We have based these forward-looking statements on our current expectations and projections about future events, including our cash flow projections. These forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various risk factors. These known and unknown risk factors include, but are not limited to: the delay in obtaining or the failure to obtain regulatory approvals for our products and the products of our licensees that may generate royalty and milestone payments to us, our ability to achieve product sales and royalties, competition, our dependence on other companies to commercialize, manufacture and sell
'/>"/>
SOURCE Unigene Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Unigene Provides 2012 Business Outlook
2. Unigene to Present at Biotech Showcase™ 2012 in San Francisco on January 9
3. Unigenes Proprietary Peptelligence™ Platform Used to Commence Cara Therapeutics Phase 1 Clinical Trial of Oral Novel Peripherally-Acting Kappa Opioid Agonist
4. Unigene Strengthens Board with the Appointment of Walgreens Executive, Thomas J. Sabatino, Jr.
5. Unigene Reports Third Quarter 2011 Financial Results
6. Unigene to Announce Third Quarter 2011 Financial Results on November 9, 2011
7. Webcast Alert: Unigene Laboratories, Inc. (UGNE) Announces Third Quarter 2010 Earnings Conference Call
8. Bedford Laboratories™ Issues Guidance on 2011 Voluntary Recall of Polymyxin B for Injection USP and Vecuronium Bromide for Injection Related to Glass Particulates
9. Quest Diagnostics Completes Acquisition of S.E.D. Medical Laboratories
10. IDEXX Laboratories to Present at J.P. Morgan Healthcare Conference
11. Abaxis Veterinary Reference Laboratories Now Offering Quantitative Lyme Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... MUMBAI, India , July 4, 2015 /PRNewswire/ ... médicale continue cible les épidémies que sont l,hypertension, ... centrale et du Sud-Est, par l,intermédiaire de plateformes ... ces maladies.      (Photo: http://photos.prnewswire.com/prnh/20150630/227090 ... Prendre en charge le diabète en ligne , ...
(Date:7/3/2015)... MUMBAI , July 3, 2015 /PRNewswire/ ... gab heute bekannt, vorbehaltlich bestimmter Abschlussbedingungen eine ... Russland erworben zu haben. Mit dieser Übernahme ... der mit einem Umsatz von 765 Mrd. ... größten Pharmamärkten der Welt gehörte (IMS Health). ...
(Date:7/2/2015)... HILL, N.C. , July 2, 2015 /PRNewswire/ ... own employees to capture critical product and market ... are many benefits to employee-based studies, it is ... leverage their own internal employees to capture critical ... study by benchmarking firm, Best Practices, LLC, most ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 3Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3Leveraging Employee Insights to Produce Cutting-Edge Market Research 2
... PITTSBURGH, Sept. 21 Mylan Inc. (Nasdaq: ... the U.S. District Court for the District of New ... selling or shipping or otherwise launching … or importing" ... Paxil CR, Paroxetine Hydrochloride (HCl) Extended-release (ER) Tablets, 12.5 ...
... Sept. 21 More than one in three ... as prescribed, stating that they have done so on average ... physicians estimate that in reality this number could be as ... Patients and Physicians in Insulin Therapy (GAPP™) survey, released today ...
Cached Medicine Technology:New Global Survey Reveals Over One in Three Patients Fail to Take Insulin as Prescribed 2New Global Survey Reveals Over One in Three Patients Fail to Take Insulin as Prescribed 3
(Date:7/5/2015)... ... July 05, 2015 , ... Doctors at the Swedish Cancer Institute in Seattle, ... day change the outlook for people with pleural mesothelioma. Surviving Mesothelioma has just posted ... report that five mesothelioma patients treated with 25Gy of radiation over five days just ...
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler ... recognition of technical sales expertise from the North American Board of Certified Energy ... is the most highly respected and well established national certification organization for renewable ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Scientists at ... susceptible to mesothelioma with even minimal asbestos exposure. Click here to read the ... the University of Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University ...
(Date:7/3/2015)... ... 2015 , ... Smoothies are all the rage right now and all you ... ingredients. Aurora Natural is proud to introduce a new line of all natural products ... vitamins and minerals! , Aurora is offering a variety of blends and stand-alone items ...
(Date:7/3/2015)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, ... and expose popular lies regarding proper relationships according to the bible. , ... the core of the subject by explaining why certain types of sexual relationships are ...
Breaking Medicine News(10 mins):Health News:New Mesothelioma Study Calls IMRT/Surgery Combo “Innovative and Promising”, According to Surviving Mesothelioma 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2
... physically abused in Germany. Many more, some 12,000 to 13,000, ... statistics, but in fact a high proportion of unreported cases ... Deutsches rzteblatt International contains an article in which Winfried ... present the findings of their representative survey of a sample ...
... Men and women infected with HIV reduced the risk of ... antiretroviral medicines when their immune systems were relatively healthy, according ... National Institute of Allergy and Infectious Diseases (NIAID), part of ... known as HPTN 052, was slated to end in 2015 ...
... Medical imaging facilities can now submit anonymized dose information ... (DIR) allowing them to compare their dose indices to ... national benchmarks. Participating facilities receive periodic feedback comparing their dose ... adjustments to lower dose received from scans. ...
... more than 35 years experience in breast imaging, has been ... of Radiology (ACR), the organization,s highest honor given for distinguished ... award will be presented to Bassett May 15 at the ... proud to be recognized by my peers for my contributions ...
... A Nordic multicentre study, headed by researchers from Karolinska ... using synthetic mesh can be more effective than traditional ... restored genital anatomy and more efficient symptom relief, although ... study is published in the renowned scientific periodical The ...
... that the vast majority of patients at high risk for ... statins as prescribed. That,s especially unfortunate, because the same study ... length of those patients, lives. "We found that only ... taking their prescribed dose on a regular basis after one ...
Cached Medicine News:Health News:Treating HIV-infected people with antiretrovirals significantly reduces transmission to partners 2Health News:Treating HIV-infected people with antiretrovirals significantly reduces transmission to partners 3Health News:Treating HIV-infected people with antiretrovirals significantly reduces transmission to partners 4Health News:ACR launches dose index registry 2Health News:UCLA cancer researcher wins prestigious Gold Medal from the American College of Radiology 2Health News:Synthetic mesh can improve outcome of prolapse surgery 2Health News:Study: Most at-risk patients don't adhere to statin treatment, despite real benefits 2
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
Single-action, stainless steel micro biopsy forceps....
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
Medicine Products: